Table 3.

Distribution of gender based on age group and different types of vaccines (n = 682).

(A) The First Dose
Age Group	Vaccine (n)	n (%)	Gender for Adverse Effects		Odds Ratio	p-Value
			Male (n = 408)	Female (n = 274)
18–34 years old	Total	121	61	60
		(100%)	(50.41%)	(49.59%)
	Astra	57	32	25	2.67	0.064
		(100%)	(56.14%)	(43.86%)	(1.07–6.72)
	Moderna	33	19	14	2.85
		(100%)	(57.58%)	(42.42%)	(1.03–7.92)
	Pfizer	31	10	21	1
		(100%)	(32.26%)	(67.74%)
35–54 years old	Total	453	269	184
		(100%)	(59.38%)	(40.62%)
	Astra	255	163	92	1.28	0.028 *
		(100%)	(63.92%)	(36.08%)	(0.81–2.02)
	Moderna	86	41	45	0.66
		(100%)	(47,67%)	(52.33%)	(0.37–1.16)
	Pfizer	112	65	47	1
		(100%)	(58.04%)	(41.96%)
≥55 years old	Total	108	78	30
		(100%)	(72.22%)	(27.78%)
	Astra	41	30	11	1.07	0.985
		(100%)	(73.17%)	(26.83%)	(0.40–2.86)
	Moderna	28	20	8	0.98
		(100%)	(71.43%)	(28.57%)	(0.33–2.88)
	Pfizer	39	28	11	1
		(100%)	(71.79%)	(28.21)
(B) The second dose
Age Group	Vaccine (n)	n (%)	Gender for Adverse Effects		Odds Ratio	p -Value
			Male (n = 408)	Female (n = 274)
18–34 years old	Total	121	61	60
		(100%)	(50.41%)	(49.59%)
	Astra	39	26	13	4.4	0.002 *
		(100%)	(66.67%)	(33.33%)	(1.78–10.86)
	Moderna	34	20	14	3.14
		(100%)	(58.82%)	(41.18%)	(1.26–7.85)
	Pfizer	48	15	33	1
		(100%)	(31.25%)	(68.75%)
35–54 years old	Total	453	269	184
		(100%)	(59.38%)	(40.62%)
	Astra	189	119	70	1.09	0.059
		(100%)	(62.96%)	(37.04%)	(0.71–1.66)
	Moderna	87	42	45	0.60
		(100%)	(48.28%)	(51.72%)	(0.36–1.00)
	Pfizer	177	108	69	1
		(100%)	(61.02%)	(38.98%)
≥55 years old	Total	108	78	30
		(100%)	(72.22%)	(27.78%)
	Astra	28	20	8	1.04	0.875
		(100%)	(71.43%)	(28.57%)	(0.38–2.88)
	Moderna	29	22	7	1.31
		(100%)	(75.86%)	(24.14%)	(0.46–3.71)
	Pfizer	51	36	15	1
		(100%)	(70.59%)	(29.41%)

(*): p < 0.05.